Regulation of gene expression by corticoid hormones in the brain and spinal cord

Journal of Steroid Biochemistry and Molecular Biology

Volumn 65, Issue 1-6, 1998, Pages 253-272

  De Nicola, Alejandro F ^a,b   Ferrini, Monica ^a   Gonzalez, Susana L ^a,b   Gonzalez Deniselle, Maria Claudia ^a,b   Grillo, Claudia A ^a,b   Piroli, Gerardo ^a,b   Saravia, Flavia ^a,b   De Kloet, E Ronald ^c  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; ARGIPRESSIN; CORTICOSTEROID; DEXAMETHASONE; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN;

ANIMAL CELL; ANIMAL TISSUE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; GENE EXPRESSION REGULATION; HORMONAL REGULATION; IMMUNOREACTIVITY; NEUROPATHOLOGY; NONHUMAN; RAT; REGULATORY MECHANISM; SEX DIFFERENCE; SPINAL CORD TRANSSECTION;

ADRENAL CORTEX HORMONES; ANIMALS; ARGININE VASOPRESSIN; BRAIN; FEMALE; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; NA(+)-K(+)-EXCHANGING ATPASE; RATS; SEX CHARACTERISTICS; SPINAL CORD;

ANIMALIA; EUKARYOTA;

EID: 0032053204     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00190-8     Document Type: Conference Paper

References (134)

1. McEwen B. S., De Kloet E. R., Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol. Rev. 66:1986;1121-1188.
2. Joels M., de Kloet E. R. Mineralocorticoid and glucocorticoid receptors in the brain. Implication for ion permeability and transmitter systems. Prog. Neurobiol. 43:1994;1-36.
3. Beato M., Candau R., Chavez S., Mows C., Truss M. Interaction of steroid hormone receptors with transcription factors involves chromatin remodelling. J. Steroid Biochem. Mol. Biol. 56:1996;47-59.
4. Pearce D., Yamamoto K. R. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science. 259:1993;1161-1165.
5. Trapp T., Rupprecht R., Castren M., Reul J. M. H. M., Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptor: A new principle of glucocorticoid action in the CNS. Neuron. 13:1994;1457-1462.
6. Bamberger C. M., Bamberger A. M., Castro M., Chrousos G. P. Glucocorticoid receptor β: A potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95:1995;2435-2441.
7. Lombes M., Kenouch S., Souque A., Farman N., Rafesstin-Oblin M. E. The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11β-hydroxysteroid dehydrogenase. Endocrinology. 135:1994;834-840.
8. Low S. C., Moison M.-P., Noble J. M., Edwards C. R. W., Seckl J. R. Glucocorticoids regulate hippocampal 11β-hydroxysteroid dehydrogenase activity and gene expression in vivo in the rat. J. Neuroendocrinol. 6:1994;285-290.
9. A receptor. Mol. Neurobiol. 3:1989;275-304.
10. Dubrovsky B., Gijsbers K., Filipini D., Birmingham M. K. Efects of adrenocortical steroids on long-term potentiation in the limbic system: Basic mechanisms and behavioral consequences. Cell. Mol. Neurobiol. 13:1993;399-414.
11. Orchinik M., Murray T. F., Moore F. L. A corticosteroid receptor in neuronal membranes. Science. 252:1991;1848-1851.
12. Hall E. D. Neuroprotective action of glucocorticoid and non glucocorticoid steroids in acute neuronal injury. Cell. Mol. Neurobiol. 13:1993;415-432.
13. Singh V. B., Corley K. C., Pham T.-H., Boadle-Biber M. C. Increases in the activity of tryptophan hydroxylase from rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment. Brain Res. 516:1990;66-76.
14. Bau D., Vernadakis A. Effects of corticosterone on brain cholinergic enzymes in chick embryos. Neurochem. Res. 7(7):1982;821.
15. Kumer S. C., Vrana K. E. Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67:1996;443-462.
16. Wurtman E. J., Axelrod J. Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal corticoids. J. Biol. Chem. 241:1966;2301-2304.
17. Paivarinta H., Soinila S., Eranko O., Joh T. H. Phenylethanolamine-n-methyltransferase immunoreactive cells in developing rat superior cervical ganglion and the effect of hydrocortisone on their number. Int. J. Devl. Neurosci. 3:1985;9-18.
18. Sabban E. L., Goldstein M., Greene L. A. Regulation of the multiple forms of dopamine β-hydroxylase by nerve growth factor, dexamethasone. and dibutyryl cyclic AMP in the PC12 pheochromocitoma cell line. J. Biol. Chem. 258:1983;7819-7823.
19. Harrelson A. L., Rostene W., McEwen B. S. Adrenocortical steroids modify neurotransmitter-stimulated cyclic AMP accumulation in the hippocampus and limbic brain of the rat. J. Neurochem. 48:1987;1648-1655.
20. Yoshikawa K., Sabol S. Glucocorticoids and cyclic AMP synergistically regulate the abundance of preproenkephalin messenger RNA in neuroblastoma-glioma hybrid cells. Biochem. Biophys. Res. Commun. 139:1986;1-10.
21. Daya S., Joubert P. H. Glucocorticoid reversal of cyclic AMP down regulation in the rat pineal gland. IRSC Med. Sci. 12:1984;1957.
22. Maines M. D., Eke B. C., Zhao X. D. Corticosterone promotes increased heme oxygenase-2 protein and transcript expression in the newborn rat brain. Brain Res. 722:1996;83-84.
23. Maines M. D., Eke B. C., Weber C. M., Ewing J. F. Corticosterone has a permissive effect on expression of heme oxygenase-1 in CA1-CA3 neurons of hippocampus in thermal-stressed rats. J. Neurochem. 64:1995;1769-1779.
24. iα messenger RNA and protein in rat cerebral cortex. Proc. Nat. Acad. Sci. USA. 86:1989;3906-3910.
25. Krugers H., Medema R., Postema F., Korf J. Region-specific alterations of calbindin-D28k immunoreactivity in the rat hippocampus following adrenalectomy and corticosterone treatment. Brain Res. 696:1995;89-96.
26. Elliot E. M., Sapolsky R. M. Corticosterone enhances kainic acid-induced calcium mobilization in cultured hippocampal neurons. J. Neurochem. 59:1992;1033-1038.
27. Cousin M. A., Lando D., Moguilewsky M. Ornithine decarboxylase induction by glucocorticoids in brain and liver of adrenalectomized rats. J. Neurochem. 38:1982;1296-1304.
28. de Kloet E. R., Cousin M. A., Veldhuis H. D., Voorhhuis Th. D., Lando D. Glucocorticoids modulate the response of ornithine decarboxylase to unilateral removal of the dorsal hippocampus. Brain Res. 275:1983;91-98.
29. Orti E., Moses D. F., Grillo C., De Nicola A. F. Glucocorticoid regulation of glycerolphosphate dehydrogenase and ornithine decarboxylase activities in the spinal cord of the rat. J. Neurochem. 48:1987;425-431.
30. Gonzalez S., Moses D. F., De Nicola A. F. Glucocorticoid receptors and enzyme induction in the spinal cord of rats: Effects of acute transection. J. Neurochem. 54:1990;834-840.
31. Gonzalez S. L., Coirini H., Gonzalez Deniselle M. C., Gonzalez S., Calandra R., De Nicola A. F. Time-dependent effects of dexamethasone on glutamate binding, ornithine decarboxylase activity and polyamine levels in the transected spinal cord. J. Steroid Biochem. Mol. Biol. 55:1995;85-92.
32. Ientile R., De Luca G., Di Giorgio R. M., Macaione S. Glucocorticoid regulation of spermidine acetylation in the rat brain. J. Neurochem. 51:1988;677-682.
33. De Nicola A. F. Steroid hormones and neuronal regeneration. Adv. Neurol. 59:1993;199-206.
34. Masters J. N., Finch C. E., Nichols N. R. Rapid increase in glycerol phosphate dehydrogenase mRNA in adult rat brain: A glucocorticoid-dependent stress response. Neuroendocrinology. 60:1994;23-35.
35. Meyer J. S., Leveille P. J., Vellis J., Gerlach J. L., McEwen B. S. Evidence for glucocorticoid target cells in the rat optic nerve. Hormone binding and glycerol phosphate dehydrogenase induction. J. Neurochem. 39:1982;423-434.
36. Beron J., Verrey F. Aldosterone induces early activation and late accumulation of Na,K-ATPase at surface of A6 cells. Am. J. Physiol. 266:1994;C1278-C1290.
37. Grillo C., Coirini H., McEwen B. S., De Nicola A. F. Changes in salt intake and of (Na+K)ATPase activity in brain after high dose treatment with deoxycorticosterone. Brain Res. 499:1989;225-233.
38. Schulkin J., Marini J., Epstein A. A role for the medial region of the amygdala in mineralocorticoid-induced salt hunger. Behav. Neurosci. 103:1989;178-185.
39. Vallee S. M., Grillo C., Gonzalez S., Cosenbinker L., de Kloet E. R., McEwen B. S., De Nicola A. F. Further studies in deoxycorticosterone-acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors ad effects of antagonists on salt intake. Neuroendocrinology. 61:1995;117-124.
40. Sakai R. R., Ma L. Y., Zhang D. M., McEwen B. S., Fluharty S. Intracerebral administration of mineralocorticoid receptor antisense oligonucleotides attenuate adrenal steroid-induced salt appetite in rats. Neuroendocrinology. 64:1996;425-429.
41. McEwen B. S., Lambdin L. T., Rainbow T. C., De Nicola A. F. Aldosterone effects on salt appetite in adrenalectomized rats. Neuroendocrinology. 43:1986;38-43.
42. Magariños A. M., Coirini H., De Nicola A. F., McEwen B. S. Mineralocorticoid regulation of salt intake is preserved in hippocampectomized rats. Neuroendocrinology. 44:1986;494-497.
43. McEwen B. S., Cameron H., Chao H., Gould E., Magariños A. M., Watanabe Y., Wooley C. Adrenal steroids and plasticity of hippocampal neurons: Towards an understanding of underlying cellular and molecular mechanisms. Cell. Mol. Neurobiol. 13:1993;457-482.
44. Grillo C., Piroli G., McEwen B. S., De Nicola A. F. Glucocorticoid regulation of mRNA encoding (Na+K)ATPase α3 and β1 subunits in rat brain measured by in situ hybridization. Brain Res. 657:1994;83-91.
45. Lees G. J. Inhibition of sodium-potassium-ATPase: A potential ubiquitous mechanism contributing to central nervous neuropathology. Brain Res. Rev. 16:1991;283-300.
46. De Nicola A. F., Moses D. F., Gonzalez S., Orti E. Adrenocorticoid action in the spinal cord: Some unique molecular properties of glucocorticoid receptors. Cell. Mol. Neurobiol. 9:1989;179-192.
47. Ferrini M., Gonzalez S., Antakly T., De Nicola A. F. Immunocytochemical localization of glucocorticoid receptors in the spinal cord: Effects of adrenalectomy, glucocorticoid treatment, and spinal cord transection. Cell. Mol. Neurobiol. 13:1993;387-397.
48. Bracken M. B., Shepard M. J., Collins W. F.et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. New Engl. J. Med. 322:1990;1405-1411.
49. +-ATPase mRNA and ouabain binding in spinal cord ventral horn. J. Neurochem. 63:1994;1962-1970.
50. Gonzalez S., Grillo C., Gonzalez Deniselle M. C., Lima A., McEwen B. S., De Nicola A. F. Dexamethasoe up-regulates mRNA for Na,K-ATPase in some spinal cord neurones after cord transection. Neuroreport. 7:1996;1041-1044.
51. 2+ exchanger. J. Neurosci. 16:1996;545-552.
52. Nicot A., Rostene W., Berod A. Hypercorticism induces neurotensin mRNA in rat periventricular hypothalamus. Neuroreport. 6:1995;2158-2160.
53. Harrison R., McNeil G., Dobner P. R. Synergistic activation of neurotensin/neuromedin N gene expression by c-jun and glucocorticoids: Novel effects of fos family proteins. Mol. Endocrinol. 9:1995;981-993.
54. Lam K. S. L., Fong Lee M., Ping Tam S., Srivastava G. Gene expression of the receptor for growth-hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen. Neuroendocrinology. 63:1996;475-480.
55. Nobou F., Besson J., Rostene W., Rosselin G. Ontogeny of vasoactive intestinal peptide and somatostatin in different structures of the rat brain: Effects of hypo- and hypercorticism. Dev. Brain Res. 20:1985;296-301.
56. Watanobe H. The immunostaining for the hypothalamic vasoactive intestinal peptide, but not for β-endorphin, dynorphin-A or methionine-enkephalin, is affected by the glucocorticoid milieu in the rat: Correlation with the prolactin secretion. Reg. Peptides. 28:1990;301-311.
57. Tempel D., Leibowitz S. Adrenal steroid receptors: Interactions with brain neuropeptide systems in relation to nutrient intake and metabolism. J. Neuroendocrinol. 6:1994;479-501.
58. Luo L. G., Bruhn T., Jackson I. M. D. Glucocorticoids stimulate thyrotropin-releasing hormone gene expression in cultured hypothalamic neurons. Endocrinology. 136:1995;4945-4950.
59. Ayabayashi A., Watanabe Y., Gabriel S. M., Chase H. J., Leibowits S. F. Hypothalamic galanin-like immunoreactivity and its gene expression in relation to circulating corticosterone. Mol. Brain Res. 25:1994;305-312.
60. Landry M., Roche D., Calas A. Short-term effects of centrally administered galanin on the hyperosmostically stimulated expression of vasopressin in the rat hypothalamus. Neuroendocrinology. 61:1995;393-404.
61. Antony F. A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrinol. 14:1993;76-122.
62. Chai Z., Alheim K., Lundkvist J., Gatti S., Bartfai T. Subchronic glucocorticoid pretreatment reversibly attenuates IL-1β induced fever in rats; IL-6 mRNA is elevated while IL-1α and IL-1β mRNAs are suppressed in the CNS. Cytokine. 8:1996;227-237.
63. Smith T., Flower R. J., Buckingham J. C. Lipocortins 1, 2 and 5 in the central nervous system and pituitary gland of the rat: Selective induction by dexamethasone of lipocortin 1 in the anterior pituitary gland. Mol. Neuropharmacol. 3:1993;45-55.
64. Swanson L. W., Simmons D. M. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat. J. Comp. Neurol. 285:1989;413-435.
65. Ferrini, M., Grillo, C., Piroli, G., de Kloet, E. R. and De Nicola, A. F., Sex difference in glucocorticoid regulation of vasopressin mRNA in the paraventricular hypothalamic nucleus. Cell Mol. Neurobiol., 1997, in press.
66. Angulo J. A., Ledoux M., McEwen B. S. Genomic effects of cold and isolation stress on magnocellular vasopressin mRNA-containing cells in the hypothalamus of the rat. J. Neurochem. 56:1991;2033-2038.
67. Bartanuz V., Jezowa D., Bertini L. T., Tolders F. H., Aubry J. M., Kiss J. Z. Stress-induced increase in vasopressin and corticotropin-releasing factor. Endocrinology. 132:1993;895-902.
68. Van Eekelen J. A. M., Kiss J. Z., Westphal H. M., de Kloet E. R. Immunocytochemical study on the intracellular localization of type 2 glucocorticoid receptor in the rat brain. Brain Res. 436:1987;120-128.
69. Mohr E., Richter D. Sequence analysis of the promoter region of the rat vasopressin gene. FEBS Lett. 260:1990;305-308.
70. Axelson J. F., van Leeuwen F. W. Differential localization of estrogen receptors in various vasopressin synthesizing nuclei of the rat brain. J. Neuroendocrinol. 2(2):1990;209-216.
71. Patchev V. K., Hayashi S., Orikasa C., Almeida F. X. Implications of estrogen-dependent brain organization for gender differences in hypothalamo-pituitar-adrenal regulation. FASEB J. 9:1995;419-423.
72. Crowley R. S., Amico J. A. Gonadal modulation of oxytocin and vasopresin gene expression in the hypothalamus of the osmotically stimulated rat. Endocrinology. 133:1993;2711-2718.
73. Ferrini M., Lima A., De Nicola A. F. Estradiol abolishes autologous down-regulation of glucocorticoid receptors in brain. Life Sci. 57:1995;2403-2412.
74. Burgess L. H., Handa R. J. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology. 131:1992;1261-1269.
75. Carey, M. P., Deterd, C. H., de Koning, J., Helmerhorst, F. and de Kloet, E. R., The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat, J. Endocrinology, 144 (1995), 311-321.
76. Grino M., Hery M., Paulmyer-Lacroix O., Anglade G. Estrogens decrease expression of the corticotrophin-releasing factor gene in the hypothalamic paraventricular nucleus and of the proopiomelanocortin gene in the anterior pituitary of ovariectomized rats. Endocrine. 3:1995;395-398.
77. Gillies G. E., Linton E. A., Lowry P. J. Corticotropin-releasing activity of the new CRF is potentiated severa times by vasopressin. Nature. 299:1992;355-357.
78. Holmes M. C., Antoni F. A., Catt K. J., Aguilera G. Predominant release of vasopressin vs corticotropin-releasing factor from the isolated media eminence after adrenalectomy. Neuroendocrinology. 43:1986;245-251.
79. Laping N. J., Nichols N. R., Day J. R., Johnson S. A., Finch C. E. Transcriptional control of glial fibrillary acidic protein and glutamine synthetase in vivo shows opposite reponses to corticosterone in the hippocampus. Endocrinology. 135:1994;1928-1933.
80. Bunneman B., Lippoldt A., Aguirre J. A., Cintra A., Metzger R. Glucocorticoid regulation of angiotensinogen gene expression in discrete areas of the male rat brain. Neuroendocrinology. 57:1993;856-862.
81. Sernia C., Thomas W. G. A novel inhibitory role for glucocorticoids in the secretion of angiotensinogen by C6 glioma cells. J. Neurochem. 62:1994;1296-1301.
82. Riftina F., Angulo J., Pompei P., McEwen B. S. Regulation of angiotensinogen gene expression in the rat forebrain by adrenal steroids and relation to salt appetite. Mol. Brain Res. 33:1995;201-208.
83. Hinasaga K., Sagar S. M., Koistinaho J., Hicks K. J., Sharp F. R. VIP-induced stellation and immediate early gene expression in astrocytes: Effects of dexamethasone. Neurosci. Lett. 156:1993;57-60.
84. Engele J., Lehner M. Regulation of glial-derived dopaminergic growth factors by glucocorticoids and protein kinase C. Exp. Neurol. 133:1995;18-24.
85. Pekny M., Levéen P., Pekna M., Eliasson C., Berthold C. H., Westermark B., Betsholz C. Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J. 14:1995;1590-1598.
86. O'Banion M. K., Young D. A., Bohn M. C. Corticosterone-responsive mRNAs in primary rat astrocytes. Mol. Brain Res. 22:1994;57-68.
87. Mitsumoto, A. and Bradley, W. G., Murine motor neuron disease (the Wobbler mouse): degeneration and regeneration of the lower motor neuron. Brain Res. 105 (1982) 811-834.
88. Gonzalez Deniselle M. C., Gonzalez S. L., Piroli G., Lima A. E., De Nicola A. F. The 21-Aminosteroid U-74389F increases the number of glial fibrillary acidic protein-expressing astrocytes in the spinal cord of control and Wobbler mice. Cell. Mol. Neurobiol. 16:1996;61-72.
89. Gonzalez Deniselle, M. C., Gonzalez, S. L., Piroli, G., Ferrini, M., Lima, A. E. and De Nicola, A. F., Glucocorticoid receptors and actions in the spinal cord of the wobbler mouse, a model for neurodegenerative diseases. J. Steroid Biochem. Mol. Biol. 60 (1997) 205-213.
90. Eng L. F., Ghirnikar R. S. GFAP and astrogliosis. Brain Pathol. 4:1994;229-237.
91. Kaur C., Wu C. H., Wen C. Y., Ling E. A. The effects of subcutaneous injections of glucocorticoids on amoeboid microglia in postnatal rats. Arch. Histol. Cytol. 57:1994;449-459.
92. Kiefer R., Kreutzberg G. W. Effects of dexamethasone on microglial activation in vivo: Selective downregulation of major histocompatibility complex class II expression in regenerating facial nucleus. J. Neuroimmunol. 34:1991;99-108.
93. Bartholdi D., Schwab M. E. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res. 672:1995;177-186.
94. Kupersmith M. J., Kaufman D., Paty D. W., Ebers G., McFarland H., Johnson K., Reingold S., Whitaker J. Megadose costicosteroids in multiple sclerosis. Neurology. 44:1994;1-4.
95. Uitdehaag M. B. J., Polman C. H., Sontrop K., Dijkstra C. D. The effect of the 21-aminosteroid U74006F on the clinical course of acute experimental allergic encephalomielitis. J. Neurol. Sci. 135:1996;18-20.
96. Feasby R. E., Hahn A. F., Lovgren D., Wilkie L. Lewis rat EAN is suppressed by the 21-aminosteroid tirilazad mesylate (U-74006F). Neuropathol. Appl. Neurobiol. 20:1994;384-391.
97. Lindsay R. M., Wiegand S. J., Altar C. A., DiStefano P. S. Neurotrophic factors: From molecules to man. TINS. 17:1994;182-190.
98. Mochetti I., Wrathall J. R. Neurotrophic factors in central nervous system trauma. J. Neurotrauma. 12:1995;853-870.
99. Lindvall O., Kokaia Z., Bengzon J., Elmer E., Kokaia M. Neurotrophins and brain insults. TINS. 17:1994;490-497.
100. Chao H. M., McEwen B. S. Glucocorticoids and the expression of mRNAs for neurotrophins, their receptors and GAP-43 in the rat hippocampus. Mol. Brain Res. 26:1994;271-276.
101. Mocchetti I., Spiga G., Hayes V. Y., Isackson P. J., Colangelo A. Glucocorticoids differentially increase nerve growth factor and basic fibroblast growth factor expression in the rat brain. J. Neurosci. 16:1996;2141-2148.
102. Rabizadeh S., Oh J., Zhong L. T., Yang J., Bitler C. M., Butcher L. L., Bredesen D. E. Inductionof apoptosis by the low-affinity NGF receptor. Science. 261:1993;345-348.
103. Batuman O. A., Ferrero A., Cupp C., Jimenez S. A., Khalili K. Differential regulation of transforming growth factor β-1 gene expression by glucocorticoids in human T and glial cells. J. Immunol. 155:1995;4397-4405.
104. Federoff H. J., Grabczyk E., Fishman M. C. Dual regulation of GAP-43 gene expression by nerve growth factor and glucocorticoids. J. Biol. Chem. 263:1988;19290-19295.
105. Jacobson L., Sharp F. R., Dallman M. F. Induction of fos-like immunoreactivity in hypothalamic corticotropin-releasing factor neurons after adrenalectomy in the rat. Endocrinology. 126:1990;1709-1719.
106. Helmreich D. L., Cullinan W. E., Watson S. J. The effect of adrenalectomy on stress-induced c-fos mRNA expression in the rat brain. Brain Res. 706:1996;137-144.
107. Heck S., Kullmann M., Gast A., Pota H., Rahmsdorf H. J., Herrlich P., Cato A. C. B. A distinct modulating domain in the glucocorticoid receptor monomers in the repression of the transcription factor AP1. EMBO J. 13:1994;4087-4095.
108. Unlap T., Jope R. S. Diurnal variation in kainate-induced AP-1 activation in rat brain: Influence of glucocorticoids. Mol. Brain Res. 28:1995;193-200.
109. Grange E., Lepetit P., Baubet V., Giaume M., Leclerc M., Gay N., Gagnon J., Bobillier P. Adrenalectomy-induced increase of brain protein synthesis is antagonized by corticosterone replacements in free-moving rats. J. Neurochem. 62:1994;1079-1088.
110. Nichols N. R., Masters J. N., May P. C., de Vellis J., Finch C. E. Corticosterone-induced responses in rat brain RNA are also evoked in hippocampus by acute vibratory stress. Neuroendocrinology. 49:1989;40-46.
111. Vreugdenhil E., de Jong J., Busscher J. S., de Kloet E. R. Kainic acid-induced gene expression in the rat hippocampus is severely affected by adrenalectomy. Neurosci. Lett. 212:1996;75-78.
112. Patchev V. K., Brady L. S., Karl M., Chrousos G. P. Regulation of HSP90 and corticosteroid receptor mRNA by corticosterone levels in vivo. Mol. Cell. Endocrinol. 103:1994;57-64.
113. Nestler E. J., Rainbow T. C., McEwen B. S., Greengard P. Corticosterone increases the amount of protein 1, a neuron specific phosphoprotein in rat hippocampus. Science. 212:1981;1162-1164.
114. 1-tubulin expression by corticosterone during neuronal plasticity in the hippocampus. Mol. Brain Res. 15:1992;263-268.
115. Zhu W., Wiggins R. C., Konat G. W. Glucocorticoid-induced upregulation of proteolipid protein and myelin-associated glycoprotein genes in C6 cells. J. Neurosci. Res. 37:1994;208-212.
116. Belloso, E., Hernandez, J., Giralt, M., Killie, P. and Hidalgo, J., Effect of stress on mouse and rat brain metallothionein I and III mRNA levels. Neuroendocrinology 64 (1996) 430-439.
117. Gonzalez S., Ferrini M., Coirini H., Gonzalez Deniselle M. C., De Nicola A. F. Regulation of flunitrazepam binding in the dorsal horn of the spinal cord by adrenalectomy and corticosteroids. Brain Res. 589:1992;97-101.
118. 3H mice. Psychopharmacol. 101:1990;310-316.
119. Von Euler G., Fuxe K., Finnman U.-B., Agnati L. F. Acute and subchronic corticosterone treatment differentially modulates subcortical limbic and neostriatal nicotinic cholinergic receptors. Brain Res. 526:1990;122-126.
120. Biron D., Dauphin C., Di Paolo T. Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors. Neuroendocrinology. 55:1992;468-476.
121. Forster S., Harden T. K. Dexamethasoe increases β-adrenoceptor density in human astrocytoma cells. Biochem. Pharmacol. 29:1980;2151-2153.
122. Kuroda Y., Mikuni M., Nomura N., Takahashi K. Differential effect of subchronic dexamethasone treatment on serotonin-2 and β-adrenergic receptors in the rat cerebral cortex and hippocampus. Neurosci. Lett. 155:1993;195-198.
123. 1A, receptor mRNA by corticosterone. J. Neuroendocrinol. 7:1995;653-657.
124. Waters J. J., Swank M. W., Wilkinson C. W., Dorsa D. M. Evidence for glucocorticoid regulation of the rat vasopressin V1a receptor gene. Peptides. 17:1996;67-73.
125. Saito R., Ishiharada N., Ban Y., Honda K., Takano Y., Kamiya H. Vasopressin V1 receptor in rat hippocampus is regulated by adrenocortical functions. Brain Res. 646:1994;170-174.
126. Patchev V. K., Almeida O. F. X. Corticosteroid regulation of gene expression and binding characteristics of vasopressin receptors in the rat brain. Eur. J. Neurosci. 7:1995;1579-1583.
127. Swords B. H., Wyss J. M., Berecek K. H. Central vasopressin receptors are upregulated by deoxycorticosterone acetate. Brain Res. 559:1991;10-16.
128. Crofton J. T., Share B. S., Shade R. E., Lee-Kwon W. J., Manning M., Sawyer W. H. The importance of vasopressin in the development and maintenance of DOCA-salt hypertension in the rat. Hypertension. 1:1979;31-38.
129. Stanimirov D. B., McCarron R. M., Spatz M. Dexamethasone down-regulates endothelin receptors in human cerebromicrovascular endothelial cells. Neuropeptides. 26:1994;145-152.
130. De Nicola A. F., Seltzer A., Tsutsumi K., Saavedra J. M. Effects of deoxycorticosterone acetate (DOCA) and aldosterone on Sar1-angiotensin II binding and angiotensin-converting enzyme binding sites in brain. Cell. Mol. Neurobiol. 13:1993;529-539.
131. Sapolsky R. Glucocorticoids, hippocampal damage and glutamatergic synapsis. Prog. Brain Res. 86:1990;13-23.
132. Evans R. M., Arriza J. L. A molecular framework for the actions of glucocorticoids hormones in the nervous system. Neuron. 2:1989;1105-1112.
133. Moses D. F., Gonzalez S., McEwen B. S., De Nicola A. F. Glucocorticoid type II receptors of the spinal cord show lower affinity than hippocampal type II receptors. Binding parameters obtained with different experimental protocols. J. Steroid Biochem. Mol. Biol. 39:1991;5-12.
134. Marlier L. N. J. L., Patacchioli F. R., Porzio O., Bottone A., Di Grezia R., Borboni P., Lauro R., Angelucci L. Differential regulation of adrenocorticoid receptors in the hippocampus and spinal cord of adrenalectomized rats. J. Neurosci. 43:1996;526-534.